Abstract Title:

Infliximab-induced demyelination causes visual disturbance mistaken for recurrence of HLA-B27-related uveitis.

Abstract Source:

Ocul Immunol Inflamm. 2010 Dec;18(6):482-4. Epub 2010 Aug 25. PMID: 20735341

Abstract Author(s):

Marina Papadia, Carl Peter Herbort

Article Affiliation:

Centre for Specialized Ophthalmic Care (COS), Lausanne, Switzerland.


PURPOSE: To report a patient treated with infliximab for ankylosing spondylitis and HLA-B27 uveitis presenting with a scotoma in his left good eye due to infliximab-induced occipital demyelination mistaken for a uveitis recurrence.

DESIGN: Case report.

METHODS: Review of clinical features, visual field, and investigational procedures.

RESULTS: Loss of visual function could not be explained by mere ophthalmic examination. Magnetic resonance imaging showed several demyelinating lesions, explaining the patient's symptoms and signs. Infiliximab was discontinued and the scotoma disappeared.

CONCLUSION: This is the first report of infliximab-induced demyelination producing ocular symptoms and signs in a patient treated for uveitis.

Study Type : Human: Case Report

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.